Marie-Anne Burlot

Marie-Anne Burlot is a seasoned professional in the fields of in vivo and translational sciences, currently serving as Director at Coave Therapeutics since 2021, following a role as Project Manager at Medday Pharmaceuticals from 2016 to 2020, where responsibilities included managing preclinical studies, budget oversight, and regulatory document drafting. Previous experience includes serving as Scientific Director at ANIMALLIANCE and extensive research roles at INSERM, focusing on gene therapy for Alzheimer's disease during a PhD program from 2011 to 2014. Marie-Anne has a robust academic background in veterinary medicine and neuroscience, holding a Doctor of Philosophy degree from Université Paris Cité and a Doctor of Veterinary Medicine from Ecole Nationale Vétérinaire de Toulouse.